Holen Sie sich die Stockscreener-App
1.48
1.33%
-0.02
Handel nachbörslich:
1.48
Schlusskurs vom Vortag:
$1.50
Offen:
$1.51
24-Stunden-Volumen:
2.12M
Relative Volume:
2.50
Marktkapitalisierung:
$158.99M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-1.2033
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
+0.68%
1M Leistung:
+17.46%
6M Leistung:
-16.85%
1J Leistung:
-67.40%
1-Tages-Spanne:
$1.44
$1.51
1-Wochen-Bereich:
$1.355
$1.535
52-Wochen-Spanne:
$0.87
$6.78
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.48 | 158.99M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Alector appoints Neil Berkley as interim CFO - MSN
Alector (ALEC) Appoints Interim CFO as Current CFO Departs | ALE - GuruFocus
Alector Provides Executive Leadership Update | ALEC Stock News - GuruFocus
Alector, Inc. (NASDAQ:ALEC) Given Consensus Rating of “Hold” by Brokerages - Defense World
Alector Names Neil Berkley as Interim CFO - MarketScreener
Alector Provides Executive Leadership Update - GlobeNewswire
Alector, Inc. (NASDAQ:ALEC) Position Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Alector shares surge 73% following InvestingPro’s April fair value signal By Investing.com - Investing.com Australia
Cantor Fitzgerald Forecasts Alector FY2026 Earnings - Defense World
Transcript : Alector, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Nuveen Asset Management LLC - Defense World
Alector president sells shares worth $31,974 - Investing.com Australia
Alector president sells shares worth $31,974 By Investing.com - Investing.com Canada
Alector Executives Sell Shares to Cover Tax Obligations - TradingView
Are Investors Inclined To Sell Their Alector Inc (NASDAQ: ALEC) Holdings? - Stocksregister
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
Goldman Sachs Conference: Alector Reveals Next Steps in Fighting NeurodegenerationKey Updates Coming - Stock Titan
Alzheimer's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com
BNP Paribas Financial Markets Grows Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Northern Trust Corp Purchases 40,291 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
D. E. Shaw & Co. Inc. Raises Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Deutsche Bank AG Reduces Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target - BioSpace
Sanofi Makes Alzheimer’s Bet With Vigil Buy - insights.citeline.com
Top Penny Stocks To Watch In May 2025 - simplywall.st
What Did We Note About Insider Trading At Alector Inc (NASDAQ: ALEC)? - Stocksregister
Alector, Inc. (NASDAQ:ALEC) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Dimensional Fund Advisors LP Raises Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector at BofA Securities 2025 Healthcare Conference: Strategic Innovations in Brain Disorder Therapies - Investing.com
Alector Reports Increased Loss, Advances Clinical Pipeline - TipRanks
Alector stock price target raised to $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Alector stock price target raised to $10 at H.C. Wainwright - Investing.com
Alector (ALEC) to Release Quarterly Earnings on Wednesday - Defense World
Alector, Inc. (NASDAQ:ALEC) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.26 - Yahoo Finance
US$5.26That's What Analysts Think Alector, Inc. (NASDAQ:ALEC) Is Worth After These Results - simplywall.st
Alector (ALEC) Maintains Buy Rating as Price Target Increases | - GuruFocus
Alector First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Sto - GuruFocus
Alector (ALEC) Maintains Buy Rating as Price Target Increases | ALEC Stock News - GuruFocus
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Stock News - GuruFocus
Alector Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Alector Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Alector (ALEC) Reports Q1 Revenue Shortfall, Advances Drug Trials | ALEC Stock News - GuruFocus
Alector reports Q1 EPS (41c), consensus (46c) - TipRanks
Alector Inc Reports Q1 2025 Earnings: EPS Loss of $0.41 Beats Estimates, Revenue Falls Short at $3.7 Million - GuruFocus
Alector, Inc. SEC 10-Q Report - TradingView
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alector Inc-Aktie (ALEC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GRASSO MARC | Chief Financial Officer |
Jun 02 '25 |
Sale |
1.34 |
16,488 |
22,068 |
296,072 |
| Kenkare-Mitra Sara | President and Head of R&D |
Jun 02 '25 |
Sale |
1.34 |
23,890 |
31,974 |
512,252 |
| Rosenthal Arnon | Chief Executive Officer |
Jun 02 '25 |
Sale |
1.34 |
52,087 |
69,713 |
2,414,657 |
1.11%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):